Nicotine-evoked [3H]5-hydroxytryptamine release from rat striatal synaptosomes

Area of Science:

• Neuropharmacology
• Neurotransmitter Release
• Receptor Pharmacology

Background:

• Presynaptic nicotinic acetylcholine receptors (nAChRs) play a role in regulating neurotransmitter release in the brain.
• Understanding the specific subtypes and pharmacological properties of these receptors is crucial for elucidating their function in neuronal circuits.

Purpose of the Study:

• To characterize the pharmacology of presynaptic nAChRs modulating 5-hydroxytryptamine (5-HT) release from rat brain synaptosomes.
• To investigate the concentration-dependent effects of various agonists and antagonists on 5-HT release.

Main Methods:

• Superfusion of rat brain synaptosomes preloaded with [3H]5-HT.
• Application of various nicotinic agonists (nicotine, epibatidine, cytisine, acetylcholine) and antagonists (mecamylamine, dihydro-beta-erythroidine, methyllycaconitine).
• Measurement of [3H]5-HT release and determination of EC50 and IC50 values.

Main Results:

• Nicotine, epibatidine, cytisine, and acetylcholine increased 5-HT release from striatal synaptosomes in a concentration-dependent manner.
• Agonist efficacy varied, with cytisine showing lower efficacy than nicotine, acetylcholine, and epibatidine.
• Mecamylamine blocked most agonist effects, but a higher concentration of epibatidine revealed a mecamylamine-insensitive component.
• Dihydro-beta-erythroidine and methyllycaconitine inhibited nicotine-evoked release, suggesting specific nAChR subtypes are involved.

Conclusions:

• Presynaptic nAChRs directly modulate 5-HT release in the rat striatum.
• The identified nAChRs possess a unique pharmacological profile distinct from previously characterized subtypes.
• These findings contribute to understanding the role of nicotinic modulation in serotonergic neurotransmission.